Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Triple-negative breast cancer Stories

2012-10-24 15:25:49

PHILADELPHIA, Oct. 24, 2012 /PRNewswire/ -- Newly published cell research performed by at the Zheijian Provincial People's Hospital in Zheijiang China indicates that the key compound in turmeric known as curcumin is capable of inducing programmed cell death in triple-negative breast cancer cells, the most feared and prognosis-poor type of breast cancer currently recognized. The information sheds light on how turmeric, a substance even recognized by Cancer.gov as a potential cancer fighter,...

2012-09-24 13:59:47

A team of scientists with The Cancer Genome Atlas program reports their genetic characterization of 800 breast tumors, including finding some of the genetic causes of the most common forms of breast cancer, providing clues for new therapeutic targets, and identifying a molecular similarity between one sub-type of breast cancer and ovarian cancer. Their findings, which offer a more comprehensive understanding of the mechanisms behind each sub-type of breast cancer, are reported in the...

2012-09-19 15:50:04

The Vall d'Hebron Breast Cancer Unit, the Vall d'Hebron Institute of Oncology (VHIO) and SOLTI, an academic breast cancer research group are heading up a multi-center international study involving four Spanish and three North American research centers. The aim of the study is to investigate whether BKM120, a drug that inhibits the PI3K pathway (phosphatidylinositol-3-Kinase) can be an effective treatment against triple-negative breast cancer. At present it is known that breast cancer can...

2012-09-18 10:24:31

PASADENA, Calif., Sept. 18, 2012 /PRNewswire/ -- Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer Epidemiology, Biomarkers & Prevention. The 21-year study included nearly 1,000 women from Kaiser Permanente Southern California and found that molecular subtypes of breast cancer were important independent...

2012-09-13 02:28:19

WORCESTER, Mass. and TORONTO, Sept. 13, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) (www.generex.com), announced today presentation of early results from an efficacy study of an immunotherapeutic in triple negative breast cancer patients. The immunotherapeutic is being developed by Antigen Express, Inc. (www.antigenexpress.com), a wholly owned subsidiary of Generex. The results will be presented on Friday, September 14, 2012 at the 2012 Breast Cancer...

2012-08-13 15:44:51

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells. Using this method, the Jackson laboratory has identified a new oncogene, which is a gene that contributes to the development of cancer, named FAM83B. "We made our discovery in a model of breast cancer," said Mark W. Jackson, Ph.D., Assistant Professor, Department of...

2012-08-01 02:24:51

SANTA ROSA, Calif., Aug. 1, 2012 /PRNewswire/ -- Triple negative breast cancer is the most aggressive type of breast cancer and carries a very high risk of early -- and deadly -- metastasis. Current treatment for triple negative breast cancer is extremely limited. After completing the initial treatments for this deadly breast cancer, women have no viable options that can help them prevent recurrence and deadly metastasis. A new botanical formula may offer hope for this group of patients. In...

2012-07-25 02:29:10

ROCKVILLE, Md., July 25, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study. The study is sponsored by EntreMed and is supported by a grant from the National Cancer Institute. More information about the clinical trial can be found at...

Bra Size Linked To Breast Cancer Risk
2012-07-08 08:08:43

redOrbit Staff & Wire Reports - Your Universe Online The same gene that can determine a woman's breast size could also be linked to her odds of developing breast cancer, with larger cup-sizes more likely to develop tumors, according to the results of a new study California-based personal genomics and biotechnology company 23andMe. The firm reported that they were able to identify "seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three...

2012-07-02 23:13:22

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise the possibility of using this type of combination therapy for different forms of breast cancer, including those that develop resistance to chemotherapy and other treatments. The study was led by researchers at the Boston University Cancer Center. Sibaji Sarkar, PhD,...